If you have a legal question or problem related to dietary supplements, sports nutrition products, performance enhancing substances or anabolic steroids, recognized legal authority Rick Collins, Esq. may have the answers you need.  He has traveled across America in matters involving nutritional supplements and performance enhancing drugs, but sometimes he can best serve individuals and businesses with questions or cases through the retained consultation process. He has been consulted on well over a thousand matters involving sports nutritional supplements and anabolic steroids. He has assisted on anabolic steroid civil and criminal matters throughout the United States and even in foreign countries. He has worked closely with criminal defense attorneys and public defenders from coast to coast to ensure steroid cases are handled with knowledge and insight. He has been consulted for his views as a credible authority by state and city police departments. He has provided counsel to countless sports and fitness nutritional supplement companies to help ensure their compliance with federal laws and DEA and FDA regulations. He is a sought-after lecturer, and has been invited to speak at numerous events and conferences (for a list of his presentations, please see his Curriculum Vitae.  Mr. Collins appears as an authority on steroid legalities in the documentary film, “Bigger, Stronger, Faster*”. His book, Legal Muscle, has been reviewed as "the most important book ever written about steroids."

If you have a question about anabolic steroids, sports "doping" violations, ancillary bodybuilding medications, "misbranded" or "unapproved" drugs, sports nutrition dietary supplements, or any issue involving bodybuilding or sports and the law, feel free to call Rick Collins at Collins Gann McCloskey & Barry PLLC (CGMB). Consultation fees are typically hourly arrangements, but flat minimum fees apply in some cases. Call 516-294-0300 for further information or email info@cgmbesq.com. Also, visit www.steroidlaw.com, edited by Mr. Collins, for the latest developments on the topic.